Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLAT in Refractory or Relapsed Acute Myeloid Leukemia
NCT00488709Phase 4Completed
- Sponsor
- Fundación PETHEMA
- Start
- May 2003
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of fludarabine, cytarabine, topotecan in acute myeloid leukemia (AML), sponsored by Fundación PETHEMA. Started May 2003; status: completed.
02
Drugs
fludarabinecytarabinetopotecan
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00488709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00488709.